BCC Research LLC has released a study predicting that the global radiopharmaceuticals market will grow from $10.3 billion in 2024 to $21.9 billion by 2029, with a compound annual growth rate (CAGR) of 16.4%. The report analyzes market dynamics across various segments, identifying key drivers such as the rising prevalence of cancer, unmet needs in oncology, advancements in nuclear imaging technologies, and increased investment in research and development. The significance of radiopharmaceuticals in addressing medical needs is highlighted, as well as the competitive landscape of the industry.
Tue, 17 Jun 2025 18:04:42 GMT | GlobeNewswire